CAH · NYSE · STOCK
Cardinal Health (CAH) Stock Analysis
$233.74
52W $145.87 – $258.30
52/100
$54.42B
32.0
0.52
Is CAH Bullish or Bearish?
Mixed.
Innellis AI committee rates Cardinal Health (CAH) Watch with a composite score of 52/100
, based on 6 analysts with 50% agreement.
Last updated August 25, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +7.79 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -12.21 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Macro Analyst sees a compelling case. Risk Analyst remains cautious — high leverage (debt-to-equity 3.48) amplifies downside in a stress scenario. This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- ROE of 37.2% shows genuine earnings power backing the valuation — Value
- 5 consecutive earnings beats -- consistent execution — Growth
- Price structure making higher highs and higher lows — Technical
- Trend and market structure agree -- coherent bullish picture — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
- News sentiment is positive (+0.20 across 84 articles, 14d) — News
Bear Case
- P/E of 34.6 is moderate-to-rich — Value
- Price-to-book of 9.2x prices in significant intangible value — Value
- Debt-to-equity of 3.48 adds balance-sheet risk to the value case — Value
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
- MACD histogram negative -- bearish momentum — Technical
- High leverage (debt-to-equity 3.48) amplifies downside in a stress scenario — Risk
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of August 25, 2026
Overall Committee Score
52/100
Agreement
50%
Analysts
6
Conviction
Contested
Sector Rank
Top 84%
of 192 Healthcare peers
Value Analyst
neutral
45
/ 100 · High confidence
Fair value -- neither a bargain nor obviously overpriced
+ ROE of 37.2% shows genuine earnings power backing the valuation
− P/E of 34.6 is moderate-to-rich
Growth Analyst
bullish
60
/ 100 · High confidence
Strong, accelerating growth with consistent execution
+ 5 consecutive earnings beats -- consistent execution
− Growth rate is decelerating quarter over quarter -- the trend line matters more than the level
Technical Analyst
bullish
61
/ 100 · High confidence
Price action is constructive -- trend and momentum agree
+ Price structure making higher highs and higher lows
− MACD histogram negative -- bearish momentum
Risk Analyst
bearish
32
/ 100 · Moderate confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− High leverage (debt-to-equity 3.48) amplifies downside in a stress scenario
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
neutral
50
/ 100 · Moderate confidence
News flow is mixed or quiet -- no strong signal either way right now
+ News sentiment is positive (+0.20 across 84 articles, 14d)
− Negative filing: Termination of a material agreement (13d ago)
Portfolio Manager
neutral
45
/ 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 3063.01)
Investment Thesis Evolution
Committee score moved marginally from 52.2 to 52.2.
Comparing 2026-08-24 to 2026-08-25 (1 day apart).
Technical Analysis
RSI (14)
47.5
Neutral
MACD Histogram
-0.865
Bearish Momentum
Trend Direction
Sideways
Weekly: Uptrend
Market Structure
Hh Hl
Support
$220.44
Resistance
$232.96
Bollinger %B
0.39
Inside Bands
Price vs Moving Averages
EMA 9
$232.66
Above
EMA 21
$232.68
Above
EMA 50
$228.53
Above
EMA 200
$208.89
Above
Fundamental Analysis
Valuation
51
Growth
70
Profitability
8
Financial Health
53
Cash Flow
70
Valuation
P/E Ratio
32.0×
P/B Ratio
-19.02×
PEG Ratio
2.58
Dividend Yield
0.88%
52W High
$258.30
52W Low
$145.87
Quality & Growth
ROE
-5945.2%
ROA
299.1%
Gross Margin
384.4%
Operating Margin
102.8%
Revenue Growth YoY
—
Debt / Equity
-3.45
AI Fundamental Assessment
P/E ratio of 32.0 (rich relative to a 15-40x range); Price-to-book of -19.0x; PEG ratio of 2.6 (under 1.0 suggests growth is undervalued relative to price); Return on equity of -59.5%; Return on assets of 3.0%; Net margin of 0.7%; Gross margin of 3.8%; Current ratio of 0.88 (tight short-term liquidity); Debt-to-equity of -3.45; Free cash flow per share is positive (19.17); Most recent quarter beat estimates by 19.1%; 5 consecutive earnings beats; EPS growth decelerating (+20.5% -> -8.2% QoQ); Average YoY EPS growth of 39.9%; Analyst estimates flat over recent quarters
Get the Full CAH Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →